Figure 2.

ADAM9 immunohistochemistry. A-C Clear cell carcinomas with weak (A), moderate (B) and strong (C) ADAM9 protein expression. D/E Papillary (D) and chromophobe (E) renal cell carcinoma with strong ADAM9 expression. F Normal renal tissue with weak (F1) and strong (F2) ADAM9 expression.